Adults who have survived Hodgkin lymphoma (HL) for at least five years face significantly elevated long-term health risks. The researchers analyzed data from 2000 to 2017, including more than 20,000 adult HL survivors with an average age of 36. They discovered 2,899 deaths among survivors, while just 1,481 deaths would have been expected in the general population. While the majority were related to cancer, non-cancer conditions also were increased in these patients. The retrospective population-based was led by Bryan Valcarcel, M.D., instructor, and Luis Malpica Castillo, M.D., associate professor, both of Lymphoma & Myeloma.
“Thanks to advances in treatment, patients are living longer. However, our findings confirm comprehensive survivorship care focused on cardiovascular health, secondary cancers and other chronic conditions are important to improve long-term survival outcomes,” Malpica said.